Terms: = Head and neck cancer AND CYP2D6, CPD6, CYP2D, CYP2D7AP, CYP2D7BP, CYP2D7P2, CYP2D8P2, CYP2DL1, CYPIID6, P450-DB1, P450C2D, P450DB1
37 results:
1. Association of the cytochrome P450 and arylamine N-acetyltransferase gene polymorphisms with the incidence of head and neck cancer in Polish population.
Gogolewska M; Kabziński J; Majsterek I
Int J Occup Med Environ Health; 2023 Dec; 36(6):812-824. PubMed ID: 38099560
[TBL] [Abstract] [Full Text] [Related]
2. Genomic Sequencing of cancer-related Genes in Sinonasal Squamous Cell Carcinoma and Coexisting Inverted Papilloma.
Uchi R; Jiromaru R; Yasumatsu R; Yamamoto H; Hongo T; Manako T; Sato K; Hashimoto K; Wakasaki T; Matsuo M; Nakagawa T
Anticancer Res; 2021 Jan; 41(1):71-79. PubMed ID: 33419800
[TBL] [Abstract] [Full Text] [Related]
3. Prognostic value of lipid metabolism-related genes in head and neck squamous cell carcinoma.
Xiong Y; Si Y; Feng Y; Zhuo S; Cui B; Zhang Z
Immun Inflamm Dis; 2021 Mar; 9(1):196-209. PubMed ID: 33277966
[TBL] [Abstract] [Full Text] [Related]
4. Impact of cyp2d6 activity and cachexia progression on enantiomeric alteration of plasma tramadol and its demethylated metabolites and their relationships with central nervous system symptoms in head and neck cancer patients.
Suzuki K; Naito T; Tanaka H; Shibata K; Yamada Y; Itoh K; Kawakami J
Basic Clin Pharmacol Toxicol; 2021 Mar; 128(3):472-481. PubMed ID: 33131142
[TBL] [Abstract] [Full Text] [Related]
5. Association of Genetic Variants of CYP2C19 and cyp2d6 with Esophageal Squamous Cell Carcinoma Risk in Northern India, Kashmir.
Bhat GA; Bhat AB; Lone MM; Dar NA
Nutr Cancer; 2017; 69(4):585-592. PubMed ID: 28368717
[TBL] [Abstract] [Full Text] [Related]
6. Family history of cancer and the risk of squamous cell carcinoma of oesophagus: a case-control study in Kashmir, India.
Bhat GA; Shah IA; Rafiq R; Nabi S; Iqbal B; Lone MM; Islami F; Boffetta P; Dar NA
Br J Cancer; 2015 Jul; 113(3):524-32. PubMed ID: 26125444
[TBL] [Abstract] [Full Text] [Related]
7. Meta-analyses of the effect of CYP1A1 and cyp2d6 polymorphisms on the risk of head and neck squamous cell carcinoma.
Han J; Wang L; Yang Y; Zhang J
Oncol Res Treat; 2014; 37(7-8):406-11. PubMed ID: 25138301
[TBL] [Abstract] [Full Text] [Related]
8. Association of CYP1A1 and cyp2d6 gene polymorphisms with head and neck cancer in Tunisian patients.
Khlifi R; Chakroun A; Hamza-Chaffai A; Rebai A
Mol Biol Rep; 2014; 41(4):2591-600. PubMed ID: 24449363
[TBL] [Abstract] [Full Text] [Related]
9. Polymorphisms in the human cytochrome P450 and arylamine N-acetyltransferase: susceptibility to head and neck cancers.
Khlifi R; Messaoud O; Rebai A; Hamza-Chaffai A
Biomed Res Int; 2013; 2013():582768. PubMed ID: 24151610
[TBL] [Abstract] [Full Text] [Related]
10. CYP 2D6 polymorphism: a predictor of susceptibility and response to chemoradiotherapy in head and neck cancer.
Shukla P; Gupta D; Pant MC; Parmar D
J Cancer Res Ther; 2012; 8(1):40-5. PubMed ID: 22531512
[TBL] [Abstract] [Full Text] [Related]
11. Validation of genetic sequence variants as prognostic factors in early-stage head and neck squamous cell cancer survival.
Azad AK; Bairati I; Samson E; Cheng D; Mirshams M; Qiu X; Savas S; Waldron J; Wang C; Goldstein D; Xu W; Meyer F; Liu G
Clin Cancer Res; 2012 Jan; 18(1):196-206. PubMed ID: 22076708
[TBL] [Abstract] [Full Text] [Related]
12. Interaction of drug metabolizing cytochrome P450 2D6 poor metabolizers with cytochrome P450 2C9 and 2C19 genotypes modify the susceptibility to head and neck cancer and treatment response.
Yadav SS; Ruwali M; Pant MC; Shukla P; Singh RL; Parmar D
Mutat Res; 2010 Feb; 684(1-2):49-55. PubMed ID: 19954746
[TBL] [Abstract] [Full Text] [Related]
13. Genetic polymorphism of cyp2d6 influences susceptibility to papillary thyroid cancer.
Lemos MC; Carrilho F; Rodrigues F; Coutinho E; Gomes L; Carvalheiro M; Regateiro FJ
Clin Endocrinol (Oxf); 2007 Aug; 67(2):180-3. PubMed ID: 17547692
[TBL] [Abstract] [Full Text] [Related]
14. CYP1A1, cyp2d6, CYP2E1, NAT2, GSTM1 and GSTT1 polymorphisms or their combinations are associated with the increased risk of the laryngeal squamous cell carcinoma.
Gajecka M; Rydzanicz M; Jaskula-Sztul R; Kujawski M; Szyfter W; Szyfter K
Mutat Res; 2005 Jul; 574(1-2):112-23. PubMed ID: 15914211
[TBL] [Abstract] [Full Text] [Related]
15. Mutagenic activation of betel quid-specific N-nitrosamines catalyzed by human cytochrome P450 coexpressed with NADPH-cytochrome P450 reductase in Salmonella typhimurium YG7108.
Miyazaki M; Sugawara E; Yoshimura T; Yamazaki H; Kamataki T
Mutat Res; 2005 Mar; 581(1-2):165-71. PubMed ID: 15725615
[TBL] [Abstract] [Full Text] [Related]
16. [Expression of cytochrome P450 enzymes in human nasopharyngeal carcinoma and non-cancerous nasopharynx tissue].
Jiang JH; Jia WH; Qin HD; Liang H; Pan ZG; Zeng YX
Ai Zheng; 2004 Jun; 23(6):672-7. PubMed ID: 15191668
[TBL] [Abstract] [Full Text] [Related]
17. Cytochrome P450 gene polymorphism and cancer.
Agundez JA
Curr Drug Metab; 2004 Jun; 5(3):211-24. PubMed ID: 15180491
[TBL] [Abstract] [Full Text] [Related]
18. Gene polymorphisms in detoxification enzymes as susceptibility factor for head and neck cancer?
Gronau S; Koenig-Greger D; Jerg M; Riechelmann H
Otolaryngol Head Neck Surg; 2003 May; 128(5):674-80. PubMed ID: 12748560
[TBL] [Abstract] [Full Text] [Related]
19. GSTM1 enzyme concentration and enzyme activity in correlation to the genotype of detoxification enzymes in squamous cell carcinoma of the oral cavity.
Gronau S; Koenig-Greger D; Jerg M; Riechelmann H
Oral Dis; 2003 Mar; 9(2):62-7. PubMed ID: 12657030
[TBL] [Abstract] [Full Text] [Related]
20. [First results on the influence of polymorphisms at glutathione S-transferase, cytochrome P450, and tumor necrosis factor gene loci on the development of multiple head and neck cancer].
Matthias C; Jahnke V; Fryer AA; Strange RC
Laryngorhinootologie; 2003 Jan; 82(1):25-30. PubMed ID: 12548461
[TBL] [Abstract] [Full Text] [Related]
[Next]
